Skip to main content

Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical

$0.105 -0.010 (-8.70%)

High

$0.12

Low

$0.10

Trades

57

Turnover

$206,557

Volume

1,951,148
30 June 2023 at 4:10pm
If you were already registered, log in here.

[ARTICLE] Radiopharm in $10m rights issue

...

MediaBot

A news article has been posted about Radiopharm Theranostics on the AFR. The article was published around , on 18 October 2022 at 1:15pm.

Radiopharm Theranostics, which listed on the ASX last year, was expected to ask investors to tip in $10 million via an accelerated rights issue on Tuesday morning.

Read Article

RAD was $0.165 at the close of trade on 17 October 2022

Recent Articles about ASX:RAD
31-Dec Radiopharm Theranostics Limited (RADX)

finance.yahoo.com
31-Dec Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday

benzinga.com
31-Dec Radiopharm Theranostics: Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

finanznachrichten.de
31-Dec Radiopharm enters co-development partnership with Lantheus

markets.businessinsider.com
30-Dec Radiopharm Theranostics (ASX:RAD) Partners with Lantheus to Advance Radiopharmaceutical Development

kalkinemedia.com
30-Dec Radiopharm Theranostics partners with Lantheus to advance radiopharmaceutical development

grafa.com
28-Dec Radiopharm Theranostics Ltd ADR

au.investing.com
27-Dec Radiopharm Theranostics Ltd ADR

in.investing.com
27-Dec Radiopharm Theranostics Ltd ADR

in.investing.com
25-Dec Radiopharm Theranostics gets HREC approval to start study of 177Lu-labelled RAD 202 for treatment of HER2-expressing solid tumours

pharmabiz.com
Tracked

Find all articles about Radiopharm Theranostics, including others on the AFR, on the media page.

If you were already registered, log in here.

If you were already registered, log in here.

If you were already registered, log in here.